Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Strauman

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Oncology Nursing Forum|November 1, 1988
The nurse's role in the biotherapy of cancer: nursing research of side effectsJ J Strauman
Oncology Nursing Forum|September 1, 1986
Symptom distress in patients receiving Phase I chemotherapy with taxolJ J Strauman
Oncology Nursing Forum|September 1, 1988
Oncology nurse research issues: over-studied populationsJ J Strauman, P H Cotanch
The Journal of the New York State Nurses' Association|June 1, 1987
Preliminary report on the biopsychosocial effects of interleukin-2 cancer therapyJ J Strauman, K Frederickson, B S Jackson
Cancer Treatment Reports|May 1, 1985
Localized subcutaneous toxicity following bleomycin administrationJ J Strauman, N L Rosen, I Soifer, et al.
Clinical Pharmacology and Therapeutics|April 1, 1989
A phase I-II trial of 4'-deoxydoxorubicin (esorubicin) in refractory or relapsed acute leukemiaJ P Dutcher, C E Riggs, J J Strauman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1987
Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanomaP H Wiernik, E L Schwartz, A Einzig, et al.
Leukemia|July 1, 1987
Mitoxantrone and ara-C in previously treated patients with acute myelogenous leukemiaP A Paciucci, J P Dutcher, J Cuttner, et al.
Cancer Research|May 1, 1987
Phase I clinical and pharmacokinetic study of taxolP H Wiernik, E L Schwartz, J J Strauman, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Oncology Nursing Forum|November 1, 1988
The nurse's role in the biotherapy of cancer: nursing research of side effectsJ J Strauman
Oncology Nursing Forum|September 1, 1986
Symptom distress in patients receiving Phase I chemotherapy with taxolJ J Strauman
Oncology Nursing Forum|September 1, 1988
Oncology nurse research issues: over-studied populationsJ J Strauman, P H Cotanch
The Journal of the New York State Nurses' Association|June 1, 1987
Preliminary report on the biopsychosocial effects of interleukin-2 cancer therapyJ J Strauman, K Frederickson, B S Jackson
Cancer Treatment Reports|May 1, 1985
Localized subcutaneous toxicity following bleomycin administrationJ J Strauman, N L Rosen, I Soifer, et al.
Clinical Pharmacology and Therapeutics|April 1, 1989
A phase I-II trial of 4'-deoxydoxorubicin (esorubicin) in refractory or relapsed acute leukemiaJ P Dutcher, C E Riggs, J J Strauman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1987
Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanomaP H Wiernik, E L Schwartz, A Einzig, et al.
Leukemia|July 1, 1987
Mitoxantrone and ara-C in previously treated patients with acute myelogenous leukemiaP A Paciucci, J P Dutcher, J Cuttner, et al.
Cancer Research|May 1, 1987
Phase I clinical and pharmacokinetic study of taxolP H Wiernik, E L Schwartz, J J Strauman, et al.
Pageof 1